Placebo to match LY3473329 clinical trials

J2O-MC-EKBC: KRAKEN: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Oral Once-Daily LY3473329 in Adults with Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

This study is looking into a new medication for adults with high levels of 'bad' cholesterol (Lp(a)) who are at risk of heart problems. It compares the new drug to a dummy pill to see if it can lower Lp(a) and if it's safe to use.